Zoetis News - August 2026
David Rolfe's Wedgewood Partners exits its entire Zoetis (ZTS) position
In a recent 13F filing, David Rolfe's Wedgewood Partners revealed it had sold its entire stake in animal health company Zoetis. The filing, which reflects...
Polen Capital Slashes Zoetis Stake by 92%
In a significant portfolio shift, Polen Capital Management reduced its holding in animal health company Zoetis by 92.41% during the second quarter of 2026....
Tweedy Browne's Q2 13F: New Stake in Zoetis, Exits Sealed Air, Trims FedEx
In its second-quarter 13F filing, Tweedy Browne revealed a portfolio valued at $1.32 billion, a slight increase from the previous quarter. The firm, known for...
Terry Smith's Fundsmith exits $458M stake in animal health giant Zoetis
Terry Smith's Fundsmith has completely sold its position in Zoetis (ZTS), the world's largest producer of medicine and vaccinations for pets and livestock. An...
Zoetis second quarter revenue of $2.47B misses estimates as company cuts full-year 2026 guidance on companion animal weakness.
Zoetis reported flat second quarter revenue of $2.47 billion, missing consensus estimates of $2.51 billion. Adjusted EPS came in at $1.87, slightly ahead of...
Zoetis Inc Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
For the second quarter of 2026, Zoetis is expected to report consensus revenue of $2.51 billion (+0.4% YoY) and adjusted EPS of $1.84 (+4.5% YoY), while the...